Infectious Diseases Screening SolutionsFor North American Customers
“We wanted the best possible solution available on the market. Safe Entry was far superior to any other solutions we explored, and I can honestly say it lived up to all the hype and more. Identifying symptomatic individuals allowed us to keep the rest of our guests safe so that they could enjoy the festivities.”
-Michael Piper, Principal, Pied Piper Productions
Powered by Artificial Intelligence.
Our screening solutions are powered by AI. We use multispectral cameras and sensors to capture data patterns that are instantly analyzed by our AI models which continuously evolves via Machine Learning to keep you safe. That is the power of AI.
Quick, non-invasive, contactless screening
Fully automated without the need for personnel to operate
Indicates positive or negative result so safety protocols can be initiated
Watch Dr. Rahul Kushwah demonstrate the Safe Entry Station.
How does the tech respond to people who are completely asymptomatic?
Based on WHO report, an asymptomatic laboratory-confirmed case is a person infected with COVID-19 who does not develop symptoms. Asymptomatic transmission refers to transmission of the virus from a person, who does not develop symptoms. There are few reports of laboratory-confirmed cases who are truly asymptomatic, and to date, there has been no documented asymptomatic transmission. This does not exclude the possibility that it may occur. Asymptomatic cases have been reported as part of contact tracing efforts in some countries.
Data from published epidemiology and virologic studies provide evidence that COVID-19 is primarily transmitted from symptomatic people to others who are in close contact through respiratory droplets, by direct contact with infected persons, or by contact with contaminated objects and surfaces. This is supported by detailed experiences shared by technical partners via WHO global expert networks, and reports and presentations by Ministries of Health. As such based on current data, symptomatic transmission is responsible for the spread of COVID-19. Therefore, the key is to identify the majority of symptomatic individuals to prevent transmission which is the purpose of our mass screening technology.
Will I show “positive” with a common cold or flu?
At the moment, any outbreak associated with common cold or flu is by default to be associated with COVID-19. Therefore health agencies are recommending that anyone who is showing associated symptoms avoid stepping out altogether. The only definitive way of distinguishing between common cold/flu/COVID-19 is a diagnostic test. Although currently we cannot distinguish between the two, our AI algorithms are deep learning based and as there is more data analyzed by the algorithms they get smarter.
How long does the system take to process a scan?
The system can have the results usually within a fraction of a second (0.1-0.4 seconds) but at times due to low internet connectivity, it may extend to 1-2 seconds.
Does the system require installation of any other hardware?
The units provided are self-sufficient and only requires internet connectivity. Multispectral cameras installed within the units communicate with the cloud servers for analysis.
How is the Predictmedix software different from other fever scanners on the market?
The PredictMedix technology is vastly different than the other fever scanners on the market that are simply measuring body temperature. Our AI looks not only at body temperature, but at 5 specific facial points to determine if there is a truly medically induced fever, versus someone who may be hot because of outside or inside temperature conditions, etc. Before rendering a result, our AI technology also monitors and identifies the presence of other COVID-19 associated symptoms such as fatigue, headache, coughing, sneezing, blood flow, sweat gland activation, metabolism, and other key determinant factors.
What kind of internet bandwidth is required for the mass screening?
Typically internet bandwidth of above 25 Mbps is required for a single scan station.
In the News
Toronto, ON – September 14, 2021 – Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced that management has been...
Predictmedix Announces Strategic Partnership with Indian Defense Contractor for Southern Asia Region
Paras TechCare, a Division of Paras Defence, to Manufacture and Resell Safe Entry Stations into Indian Private and Public Sectors on Behalf of Predictmedix Paras Secured Two Initial High-Visibility Placements at Tier-1 Events in India; Serving as Launching Point for...
Revenue-Generating Placement to Serve as Live Demonstration of Safe Entry Station to Tier-1 Government Agencies and Event Organizers Toronto, ON – August 26, 2021 – Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”), an emerging provider of...